Objective To evaluate the efficacy and safety of intravenous diltiazem and cediland (lanatoside C) for treatment of rapid ventricular rate in atrial fibrillation and flutter.
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.